Detail Information of Transcriptional Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0159 Transporter Info | ||||
Gene Name | SLC23A2 | ||||
Transporter Name | Sodium-dependent vitamin C transporter 2 | ||||
Gene ID | |||||
UniProt ID | |||||
Transcriptional Regulation of This DT (TSR) | ||||||
---|---|---|---|---|---|---|
Class 1.1: Basic leucine zipper factors |
Click to Show/Hide the Full List of 3 TF(s) Regulating This DT |
|||||
CEBPA |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC23A2 gene | [1] | ||||
TF Protein Name |
CCAAT/enhancer-binding protein alpha | Transcription Factor Info | ||||
Tissue |
Blood; Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
CCAAT/enhancer-binding protein alpha (CEBPA) can directly bind to the SLC23A2 gene, which in turn affects the expression or function of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
CEBPB |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC23A2 gene | [2] | ||||
TF Protein Name |
CCAAT/enhancer-binding protein beta | Transcription Factor Info | ||||
Tissue |
Bone | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
CCAAT/enhancer-binding protein beta (CEBPB) can directly bind to the SLC23A2 gene, which in turn affects the expression or function of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
CREB1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC23A2 gene | [3] | ||||
TF Protein Name |
Cyclic AMP-responsive element-binding protein 1 | Transcription Factor Info | ||||
Tissue |
Blood; Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Cyclic AMP-responsive element-binding protein 1 (CREB1) can directly bind to the SLC23A2 gene, which in turn affects the expression or function of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
Class 1.2: Basic helix-loop-helix factors |
Click to Show/Hide the Full List of 6 TF(s) Regulating This DT |
|||||
ASCL1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC23A2 gene | [4] | ||||
TF Protein Name |
Achaete-scute homolog 1 | Transcription Factor Info | ||||
Tissue |
Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Achaete-scute homolog 1 (ASCL1) can directly bind to the SLC23A2 gene, which in turn affects the expression or function of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
MYOD1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC23A2 gene | [4] | ||||
TF Protein Name |
Myoblast determination protein 1 | Transcription Factor Info | ||||
Tissue |
Myotube | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Myoblast determination protein 1 (MYOD1) can directly bind to the SLC23A2 gene, which in turn affects the expression or function of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
TCF12 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC23A2 gene | [3] | ||||
TF Protein Name |
Transcription factor 12 | Transcription Factor Info | ||||
Tissue |
Blood; Embryo | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor 12 (TCF12) can directly bind to the SLC23A2 gene, which in turn affects the expression or function of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
TCF3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC23A2 gene | [4] | ||||
TF Protein Name |
Transcription factor E2-alpha | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor E2-alpha (TCF3) can directly bind to the SLC23A2 gene, which in turn affects the expression or function of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
USF1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC23A2 gene | [1] | ||||
TF Protein Name |
Upstream stimulatory factor 1 | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Brain; Colon; Embryo; Liver; Lung; Uterus | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Upstream stimulatory factor 1 (USF1) can directly bind to the SLC23A2 gene, which in turn affects the expression or function of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
USF2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC23A2 gene | [2] | ||||
TF Protein Name |
Upstream stimulatory factor 2 | Transcription Factor Info | ||||
Tissue |
Embryo; Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Upstream stimulatory factor 2 (USF2) can directly bind to the SLC23A2 gene, which in turn affects the expression or function of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
Class 1.3: Basic helix-span-helix factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
TFAP2C |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC23A2 gene | [3] | ||||
TF Protein Name |
Transcription factor AP-2 gamma | Transcription Factor Info | ||||
Tissue |
Breast; Skin | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor AP-2 gamma (TFAP2C) can directly bind to the SLC23A2 gene, which in turn affects the expression or function of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
Class 2.1: Nuclear receptors with C4 zinc fingers |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
HNF4G |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC23A2 gene | [2] | ||||
TF Protein Name |
Hepatocyte nuclear factor 4-gamma | Transcription Factor Info | ||||
Tissue |
Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Hepatocyte nuclear factor 4-gamma (HNF4G) can directly bind to the SLC23A2 gene, which in turn affects the expression or function of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
NR2F2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC23A2 gene | [4] | ||||
TF Protein Name |
COUP transcription factor 2 | Transcription Factor Info | ||||
Tissue |
Breast; Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
COUP transcription factor 2 (NR2F2) can directly bind to the SLC23A2 gene, which in turn affects the expression or function of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
Class 2.2: Other C4 zinc finger-type factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
GATA1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC23A2 gene | [4] | ||||
TF Protein Name |
Erythroid transcription factor | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Erythroid transcription factor (GATA1) can directly bind to the SLC23A2 gene, which in turn affects the expression or function of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
Class 2.3: C2H2 zinc finger factors |
Click to Show/Hide the Full List of 4 TF(s) Regulating This DT |
|||||
KLF9 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC23A2 gene | [3] | ||||
TF Protein Name |
Krueppel-like factor 9 | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Krueppel-like factor 9 (KLF9) can directly bind to the SLC23A2 gene, which in turn affects the expression or function of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
SP1 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of SLC23A2 gene in brain neuroblastoma condition | [5] | ||||
TF Protein Name |
Transcription factor Sp1 | Transcription Factor Info | ||||
Affected Drug/Substrate |
Ascorbic acid | |||||
Studied Phenotype |
Brain neuroblastoma [ICD11: 2A00.11] | |||||
Tissue |
Brain | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
C57BL/6 mice | |||||
Detailed Description |
Transcription factor Sp1 (SP1) has been reported to activate the transcription of SLC23A2 gene in brain neuroblastoma condition, which leads to an increased expression of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
Transcriptional Phenomenon 2 |
Activation of SLC23A2 gene in osteosarcoma condition | [6] | ||||
TF Protein Name |
Transcriptional repressor protein YY1 /Transcription factor Sp1 | Transcription Factor Info | ||||
Affected Drug/Substrate |
Ascorbic acid | |||||
Studied Phenotype |
Osteosarcoma [ICD11: 2B51] | |||||
Tissue |
Bone | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human osteosarcoma cells (U2OS) | |||||
Detailed Description |
The transcriptional repressor protein YY1 (YY1) and the transcription factor Sp1 (SP1) have been reported to synergistically activate transcription of the SLC23A2 gene in osteosarcoma condition, which leads to an increased expression of the drug transporter sodium-dependent vitamin C transporter 2. | |||||
SP3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of SLC23A2 gene in osteosarcoma condition | [6] | ||||
TF Protein Name |
Transcriptional repressor protein YY1 /Transcription factor Sp3 | Transcription Factor Info | ||||
Affected Drug/Substrate |
Ascorbic acid | |||||
Studied Phenotype |
Osteosarcoma [ICD11: 2B51] | |||||
Tissue |
Bone | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human osteosarcoma cells (U2OS) | |||||
Detailed Description |
The transcriptional repressor protein YY1 (YY1) and the Transcription factor Sp3 (SP3) have been reported to synergistically activate transcription of the SLC23A2 gene in osteosarcoma condition, which leads to an increased expression of the drug transporter sodium-dependent vitamin C transporter 2. | |||||
ZBTB7A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC23A2 gene | [1] | ||||
TF Protein Name |
Zinc finger and BTB domain-containing protein 7A | Transcription Factor Info | ||||
Tissue |
Bone marrow; Liver; Uterus | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Zinc finger and BTB domain-containing protein 7A (ZBTB7A) can directly bind to the SLC23A2 gene, which in turn affects the expression or function of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
Class 3.1: Homeo domain factors |
Click to Show/Hide the Full List of 4 TF(s) Regulating This DT |
|||||
HNF1A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of SLC23A2 gene in health condition | [7] | ||||
TF Protein Name |
Hepatocyte nuclear factor 1-alpha | Transcription Factor Info | ||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Hepatocyte nuclear factor 1-alpha (HNF1A), influenced by the generated by the gut microbiota and Gram negative bacteria, has been reported to activate the transcription of SLC23A2 gene in health condition, which leads to an increased expression of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
HNF1B |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Repression of SLC23A2 gene in renal cysts condition | [8] | ||||
TF Protein Name |
Hepatocyte nuclear factor 1-beta | Transcription Factor Info | ||||
Studied Phenotype |
Renal cysts [ICD11: GB80] | |||||
Tissue |
Kidney | |||||
Related DT Changes |
Down regulating | |||||
Experimental Material |
Zebrafish TgPT::EGFP) | |||||
Detailed Description |
Hepatocyte nuclear factor 1-beta (HNF1B) has been reported to repress the transcription of SLC23A2 gene in renal cysts condition, which leads to a decreased expression of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
POU2F1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC23A2 gene | [2] | ||||
TF Protein Name |
POU domain, class 2, transcription factor 1 | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
POU domain, class 2, transcription factor 1 (POU2F1) can directly bind to the SLC23A2 gene, which in turn affects the expression or function of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
ZEB1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC23A2 gene | [4] | ||||
TF Protein Name |
Zinc finger E-box-binding homeobox 1 | Transcription Factor Info | ||||
Tissue |
Blood; Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Zinc finger E-box-binding homeobox 1 (ZEB1) can directly bind to the SLC23A2 gene, which in turn affects the expression or function of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
Class 3.3: Fork head / winged helix factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
E2F6 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC23A2 gene | [1] | ||||
TF Protein Name |
Transcription factor E2F6 | Transcription Factor Info | ||||
Tissue |
Bone marrow; Embryo | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor E2F6 (E2F6) can directly bind to the SLC23A2 gene, which in turn affects the expression or function of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
FOXA1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC23A2 gene | [2] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-alpha | Transcription Factor Info | ||||
Tissue |
Breast; Embryo; Liver; Pancreatic ductal; Prostate | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Hepatocyte nuclear factor 3-alpha (FOXA1) can directly bind to the SLC23A2 gene, which in turn affects the expression or function of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
Class 3.5: Tryptophan cluster factors |
Click to Show/Hide the Full List of 3 TF(s) Regulating This DT |
|||||
FLI1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC23A2 gene | [1] | ||||
TF Protein Name |
Friend leukemia integration 1 transcription factor | Transcription Factor Info | ||||
Tissue |
Blood; Mesenchymal; Vein | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Friend leukemia integration 1 transcription factor (FLI1) can directly bind to the SLC23A2 gene, which in turn affects the expression or function of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
MYB |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC23A2 gene | [3] | ||||
TF Protein Name |
Transcriptional activator Myb | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcriptional activator Myb (MYB) can directly bind to the SLC23A2 gene, which in turn affects the expression or function of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
SPI1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC23A2 gene | [3] | ||||
TF Protein Name |
Transcription factor PU.1 | Transcription Factor Info | ||||
Tissue |
Adrenal gland; Blood; Bone marrow; Brain; Breast; Embryo; Foreskin; Heart; Intestine; Kidney; Lung; Muscle; Penis; Placenta; Renal cortex; Renal pelvis; Skin; Spinal cord; Stomach; Testes; Umbilical cord blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor PU.1 (SPI1) can directly bind to the SLC23A2 gene, which in turn affects the expression or function of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
Class 6.1: Rel homology region factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
NFKB1 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Repression of SLC23A2 gene in enterotoxigenic Escherichia coli infection condition | [9] | ||||
TF Protein Name |
Nuclear factor NF-kappa-B p105 subunit | Transcription Factor Info | ||||
Affected Drug/Substrate |
Ascorbic acid | |||||
Studied Phenotype |
Enterotoxigenic Escherichia coli infection [ICD11: 1A03.1] | |||||
Tissue |
Jejunum | |||||
Related DT Changes |
Down regulating | |||||
Experimental Material |
BALB/c mice | |||||
Detailed Description |
Nuclear factor NF-kappa-B p105 subunit (NFKB1) has been reported to repress the transcription of SLC23A2 gene in enterotoxigenic Escherichia coli infection condition, which leads to a decreased expression of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
Transcriptional Phenomenon 2 |
Repression of SLC23A2 gene in brain neuroblastoma condition | [5] | ||||
TF Protein Name |
Nuclear factor NF-kappa-B p105 subunit | Transcription Factor Info | ||||
Affected Drug/Substrate |
Ascorbic acid | |||||
Studied Phenotype |
Brain neuroblastoma [ICD11: 2A00.11] | |||||
Tissue |
Brain | |||||
Related DT Changes |
Down regulating | |||||
Experimental Material |
C57BL/6 mice | |||||
Detailed Description |
Nuclear factor NF-kappa-B p105 subunit (NFKB1) has been reported to repress the transcription of SLC23A2 gene in brain neuroblastoma condition, which leads to a decreased expression of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
Class 6.3: p53 domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
TP53 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Repression of SLC23A2 gene in health condition | [10] | ||||
TF Protein Name |
Cellular tumor antigen p53 | Transcription Factor Info | ||||
Affected Drug/Substrate |
Ascorbic acid | |||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Tissue |
Embryo | |||||
Related DT Changes |
Down regulating | |||||
Experimental Material |
mouse embryo fibroblast cell isolates | |||||
Detailed Description |
Cellular tumor antigen p53 (TP53) has been reported to repress the transcription of SLC23A2 gene in health condition, which leads to a decreased expression of the drug transporter Sodium-dependent vitamin C transporter 2. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.